Related Experiment Video
Updated: Jun 27, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Genetic determinants in ischemic heart disease.
Anna Wojtczak1, Jadwiga Skretkowicz
1Department of Pharmacogenetics, Medical University of Lódź, 90-151 Lódź, 1 Muszyńskiego St., Poland. awojtczak@pharm.am.lodz.pl
Acta Poloniae Pharmaceutica
|December 5, 2008
Summary
Genetic variations influence ischemic heart disease risk by affecting processes like atherosclerosis and blood clotting. Understanding these genetic links can lead to personalized prevention and treatment strategies.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
- Disease Etiology
Background:
- Ischemic heart disease (IHD) is a leading cause of mortality globally.
- Genetic factors play a significant role in IHD development, alongside environmental influences.
- Identifying genetic predispositions is crucial for understanding disease progression.
Purpose of the Study:
- To review current knowledge on gene polymorphism and IHD predisposition.
- To highlight key genetic pathways involved in IHD pathogenesis.
- To explore the potential for gene-based personalized medicine in IHD.
Main Methods:
- Literature review of studies on gene polymorphism and IHD.
- Analysis of genetic variants related to atherosclerosis, thrombogenesis, and fibrinolysis.
- Examination of genes involved in lipid metabolism, coagulation, and the renin-angiotensin-aldosterone system.
Main Results:
- Polymorphisms in genes affecting lipid metabolism, coagulation, and fibrinolysis are frequently studied in relation to IHD.
- Genetic variants influencing inflammation (cytokines, TNF), smooth muscle cell proliferation, and vasoactivation are also significant.
- IHD manifestation results from the accumulation of multiple genetic determinants, modified by environmental factors.
Conclusions:
- Gene polymorphism significantly contributes to ischemic heart disease predisposition.
- Understanding the genetic basis of IHD is essential for developing targeted preventive and therapeutic interventions.
- Personalized medicine approaches based on genetic profiles hold promise for IHD management.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...